Jump to content

Sign in to follow this  
Guest

Pfizer

Topic Summary

Created

Last Reply

Replies

Views

Guest -
Guest -
1
3638

Top Posters

  • Guest 1

Recommended Posts

Guest

Pfizer (+0.75%) is putting its consumer healthcare business on the trading block, either as a sale or spin-off. 

The drugmaker’s $3.4 billion unit features a medicine cabinet of popular productsyou’ll probably use at least once today, such as ChapStick, Centrum, and Advil. So what’s got Pfizer thinking about drug deals? 

Well, the $10 billion+ from a sale would give it ammo for a blockbuster acquisition(rumor on the street…it’s eyeing BMS). Plus, Pfizer is looking to zero in on its lucrative prescription drug business that has helped boost shares 7.5% YoY. 

This might be déjà vu all over again for Pfizer. It sold its consumer healthcare business to J&J back in 2006 for $16.6 billion only to buy another portfolio (which included Advil and ChapStick) when it acquired Wyeth in 2009. 

So why not write a script for one more?

https://www.morningbrew.com/stories/doctors-orders/

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this  

  • Forum Statistics

    61,995
    Total Topics
    116,463
    Total Posts
  • Member Statistics

    16,533
    Total Members
    1,592
    Most Online
    Sunny3481
    Newest Member
    Sunny3481
    Joined




×
×
  • Create New...

Important Information

Terms of Service Confirmation Terms of Use Privacy Policy Guidelines We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.